BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21035173)

  • 21. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
    Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC
    Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
    Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
    Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 25. Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology?
    Kang WD; Ju UC; Kim SM
    Gynecol Oncol; 2018 Feb; 148(2):305-310. PubMed ID: 29183629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of p16ink4a expression by fluorescence in situ hybridization in triage for high risk HPV positive in cervical cancer screening.
    Zeng WJ; Li Y; Fei HL; Cheng XD; Ye F; Lü WG; Xie X
    Gynecol Oncol; 2011 Jan; 120(1):84-8. PubMed ID: 20926123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of high-risk human papillomavirus testing in women with abnormal cytology].
    Ou H; Bian ML; Zhang XY; Chen QY; Li M; Chen Y; Liu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):608-11. PubMed ID: 18051714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions.
    Zhang Y; Wang X; Ma L; Wang Z; Hu L
    J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):368-71. PubMed ID: 19513624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or low-grade squamous intraepithelial lesion.
    Santos AL; Derchain SF; Martins MR; Sarian LO; Martinez EZ; Syrjänen KJ
    Sao Paulo Med J; 2003 Nov; 121(6):238-43. PubMed ID: 14989139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study.
    Yin G; Li J; Zhu T; Zhao X
    World J Surg Oncol; 2012 Aug; 10():168. PubMed ID: 22909227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [hTERC gene amplification and expression of human papillomavirus in cervical carcinogenesis].
    Li SH; Liu LL; Ma HX; Wang QH; Bai W
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):121-2. PubMed ID: 22455890
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
    Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The correlation of a positive DNA HPV HR test and genotyping human papilloma viruses with the presence of CIN, in women with cytologic evidence of ASC-US and LSIL].
    Bedziński M; Józefiak A; Szczepańska M; Pruski D; Kedzia W; Spaczyński M
    Ginekol Pol; 2008 Jul; 79(7):490-3. PubMed ID: 18819456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
    Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
    Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions.
    Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Pawlita M; Arbyn M;
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):406-14. PubMed ID: 23334590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Off-label high-risk HPV DNA testing of vaginal ASC-US and LSIL cytologic abnormalities at Parkland hospital.
    Chappell CA; West AM; Kabbani W; Werner CL
    J Low Genit Tract Dis; 2010 Oct; 14(4):352-5. PubMed ID: 20885164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions.
    Wang ZM
    Asian Pac J Cancer Prev; 2014; 15(2):891-4. PubMed ID: 24568514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C; Bakhiet S; Bates M; Keegan H; Pilkington L; Ruttle C; Sharp L; O' Toole S; Fitzpatrick M; Flannelly G; O' Leary JJ; Martin CM
    Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.